ArticleMolecular cancer therapeutics2018

Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain Barrier.

Minjee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.